Thesis

127 Molecular analysis for ovarian cancer detection in patient-friendly samples 29. Hentschel AE, van den Helder R, van Trommel NE, van Splunter AP, van Boerdonk RAA, van Gent M, et al. The Origin of Tumor DNA in Urine of Urogenital Cancer Patients: Local Shedding and Transrenal Excretion. Cancers (Basel). 2021;13(3). 30. Mouliere F, Smith CG, Heider K, Su J, van der Pol Y, Thompson M, et al. Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients. EMBO Mol Med. 2021;13(8):e12881. 31. Chen M, Chan RWY, Cheung PPH, Ni M, Wong DKL, Zhou Z, et al. Fragmentomics of urinary cell-free DNA in nuclease knockout mouse models. PLoS Genet. 2022;18(7):e1010262. 32. Han DSC, Ni M, Chan RWY, Chan VWH, Lui KO, Chiu RWK, et al. The Biology of Cell-free DNA Fragmentation and the Roles of DNASE1, DNASE1L3, and DFFB. Am J Hum Genet. 2020;106(2):202-14. 33. Micci F, Haugom L, Abeler VM, Davidson B, Tropé CG, Heim S. Genomic profile of ovarian carcinomas. BMC Cancer. 2014;14(1):315. 34. Sung CO, Song I-H, Sohn I. A distinctive ovarian cancer molecular subgroup characterized by poor prognosis and somatic focal copy number amplifications at chromosome 19. Gynecologic oncology. 2014;132(2):343-50. 35. van Bommel MHD, Pijnenborg JMA, van der Putten LJM, Bulten J, Snijders MPLM, Küsters-Vandevelde HVN, et al. Diagnostic accuracy of mutational analysis along the Müllerian tract to detect ovarian cancer. International Journal of Gynecologic Cancer. 2022;32(12):1568-75. 36. Barrett JE, Jones A, Evans I, Reisel D, Herzog C, Chindera K, et al. The DNA methylome of cervical cells can predict the presence of ovarian cancer. Nat Commun. 2022;13(1):448. 37. Peremiquel-Trillas P, Paytubi S, Pelegrina B, Frias-Gomez J, Carmona Á, Martínez JM, et al. An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study. Journal of Personalized Medicine. 2022;12(7):1074. 5

RkJQdWJsaXNoZXIy MjY0ODMw